Did Personality Scores Change Differently With Psilocybin Therapy and Escitalopram?
A personality score can change from baseline in one treatment group. Establishing that the change differs from another treatment requires a direct comparison. Weiss and colleagues examined that distinction in an analysis of a randomized depression trial.
What the researchers measured
The investigators compared two treatment groups, one assigned to psilocybin therapy and the other to an escitalopram-based regimen. Participants completed personality measures at baseline, six weeks and six months. The measures included broad personality domains and more specific traits such as impulsivity and absorption.
What the two comparisons showed
Several scores shifted within the psilocybin group by week six. The escitalopram group also had changes, including lower neuroticism and impulsivity scores. The authors did not find significant between-group differences. The presence of a significant change within one group and the absence of one within another would still leave the between-group question open.
How far the result extends
The study describes scores in participants receiving two treatment packages. It does not establish that psilocybin alone caused a distinctive personality change. A nonsignificant comparison also leaves open what differences a larger study could detect.
Source
Weiss B, Ginige I, Shannon L, et al. Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression. Psychological Medicine. 2024;54:178–192. DOI 10.1017/S0033291723001514.



